The law › Title 42, The Public Health and Welfare › Chapter 7

42 U.S.C. 1320f-1: Selection of negotiation-eligible drugs as selected drugs

Created in 2022 by Public Law 117-169. Not changed since. 1 bill in this Congress would change it.

How it got hereLaws that created or changed it, newest first

2022Pub. L. 117-169added it

42 U.S.C. 1320f-1Selection of negotiation-eligible drugs as selected drugs

(a)In general

(b)Selection of drugs

(c)Selected drugchanged

(d)Negotiation-eligible drug

(e)Qualifying single source drug

(f)Special rule to delay selection and negotiation of biologics for biosimilar market entryremoved

(g)Newnew

This CongressBills that change it or would

H.R. 10628Biosimilars Access and Affordability Actintroduced

past change
enacted this Congress
proposed

This Congress

H.R. 10628 Biosimilars Access and Affordability Act · introduced · would change (c), (f), (g)

How it got here

2022

Pub. L. 117–169, §11002(a)(1)(A), inserted "and subsection (b)(3)" after "the previous sentence" in concluding provisions. Law text · (a)
Pub. L. 117–169, §11002(a)(1)(B)(i), added subpar. (C). Law text · (b)
Pub. L. 117–169, §11002(a)(1)(B)(ii), added par. (3). Law text · (b)
Pub. L. 117–169, §11002(a)(1)(C), added subsec. (f). Law text · (f)

Text, outline and history from the official U.S. Code (2024 edition) on GovInfo, published by the Office of the Law Revision Counsel. Changes made after that edition appear under This Congress.